These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 8834621

  • 21. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML, Quirce Gancedo S, Juliá de Páramo B.
    Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
    [Abstract] [Full Text] [Related]

  • 22. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.
    Bilò MB, Severino M, Cilia M, Pio A, Casino G, Ferrarini E, Campodonico P, Milani M.
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):57-61. PubMed ID: 19663128
    [Abstract] [Full Text] [Related]

  • 23. [Basophil degranulation test (BDT) as a parameter of hyposensitization with Hymenoptera venoms].
    Dietschi R, Wüthrich B, Marti-Wyss S, Cuhat J.
    Schweiz Med Wochenschr; 1987 Oct 31; 117(44):1728-35. PubMed ID: 3685930
    [Abstract] [Full Text] [Related]

  • 24. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Oct 31; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 25. Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature.
    Diwakar L, Noorani S, Huissoon AP, Frew AJ, Krishna MT.
    Clin Exp Allergy; 2008 Oct 31; 38(10):1651-8. PubMed ID: 18727621
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM.
    Rev Med Chil; 2007 Dec 31; 135(12):1566-71. PubMed ID: 18357358
    [Abstract] [Full Text] [Related]

  • 30. Development of immunoglobulins to venoms during specific immunotherapy.
    Palma-Carlos ML, Santos MC, Pedro E, Branco-Ferreira M, Spínola A, Palma-Carlos AG.
    Allerg Immunol (Paris); 1999 Mar 31; 31(3):71-2. PubMed ID: 10226679
    [Abstract] [Full Text] [Related]

  • 31. Bee venom immunotherapy: clinical and immunologic observations.
    Bar-Sela S, Levo Y.
    Ann Allergy; 1981 Dec 31; 47(6):460-3. PubMed ID: 7325420
    [Abstract] [Full Text] [Related]

  • 32. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
    Ameno S, Ameno K, Fuke C, Shinohara T, Kiriu T, Kinoshita H, Ijiri I.
    Nihon Hoigaku Zasshi; 1993 Jun 31; 47(3):207-12. PubMed ID: 8345683
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Immunologic studies in allergic children].
    Urbanek R.
    Fortschr Med; 1981 Sep 10; 99(34):1367-9. PubMed ID: 7286882
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A, Boerzsoenyi J, Babilas P, Landthaler M, Szeimies RM.
    J Dtsch Dermatol Ges; 2008 Apr 10; 6(4):292-7. PubMed ID: 18042250
    [Abstract] [Full Text] [Related]

  • 37. [Determination of specific IgG4 in allergy].
    Sabbah A, Lebricon T, Penn P, Vassal V, Heulin MG.
    Allerg Immunol (Paris); 1987 Sep 10; 19(7):268-81. PubMed ID: 2455528
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of Hymenoptera venom allergy and its immunological markers current in adults in Poland.
    Nittner-Marszalska M, Liebhart J, Liebhart E, Dor A, Dobek R, Obojski A, Medrala W.
    Med Sci Monit; 2004 Jul 10; 10(7):CR324-9. PubMed ID: 15232507
    [Abstract] [Full Text] [Related]

  • 39. Early markers for protective mechanisms during rush venom immunotherapy.
    Bussmann C, Xia J, Allam JP, Maintz L, Bieber T, Novak N.
    Allergy; 2010 Dec 10; 65(12):1558-65. PubMed ID: 20584008
    [Abstract] [Full Text] [Related]

  • 40. Long-term efficacy of venom immunotherapy.
    Hafner T, DuBuske L, Kosnik M.
    Ann Allergy Asthma Immunol; 2008 Feb 10; 100(2):162-5. PubMed ID: 18320918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.